Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume

Fig. 3

a. Competing risk ROC for MTVpre (AUC = 0.71) and MTVmid (AUC = 0.76) predicting local recurrence, adjusted for competing risk of death at 3-years post-treatment. b. Cumulative incidence of local recurrence by MTVpre size quartiles. c. Cumulative incidence of local recurrence stratified by MTVpre ≥ 25 and < 25 cc . d. Cumulative incidence of local recurrence by MTVmid size quartiles. e. ROC for MTVmid predicting local recurrence, adjusted for competing risk of death for the subset with MTVpre ≥ 25 cc (AUC = 0.47) and the subset with MTVpre < 25 cc (AUC = 0.66) 36 months post-treatment. f. Cumulative incidence of local recurrence for all lesions with MTVpre < 25 cc showing those with MTVmid ≥ 13.5 cc versus < 13.5 cc have 24-month LR rates of 24.5% versus 5.3%, respectively

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us